Skip to content

PMV PHARMACEUTICALS, INC.

PMVP

CIK 0001699382

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$77.74M
−32.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.49
−29.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$69.9M
Q1 May 2026
Cash
$39.13M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
53.33M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings